{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T12:00:08Z","timestamp":1792929608070,"version":"4.5.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003952","name":"Ministry for Food, Agriculture, Forestry, and Fisheries, of Korea","doi-asserted-by":"publisher","award":["111127-3"],"award-info":[{"award-number":["111127-3"]}],"id":[{"id":"10.13039\/501100003952","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2014R1A2A2A04007791"],"award-info":[{"award-number":["2014R1A2A2A04007791"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.neuropharm.2015.04.037","type":"journal-article","created":{"date-parts":[[2015,5,15]],"date-time":"2015-05-15T01:46:13Z","timestamp":1431654373000},"page":"46-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"special_numbering":"C","title":["\u03b1-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease"],"prefix":"10.1016","volume":"97","author":[{"given":"Byung-Wook","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushruta","family":"Koppula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemant","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il-Woung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep V.","family":"More","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Su","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Don","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Kwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hwa","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Kug","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2015.04.037_bib1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1042\/bj3570593","article-title":"Nitric oxide synthases: structure, function and inhibition","volume":"357","author":"Alderton","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.yexmp.2008.10.004","article-title":"Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice","volume":"86","author":"Aoki","year":"2009","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib3","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2796.2008.01953.x","article-title":"NF-kappaB in inflammatory bowel disease","volume":"263","author":"Atreya","year":"2008","journal-title":"J.\u00a0Intern Med."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1330","article-title":"Neurodegenerative diseases and oxidative stress","volume":"3","author":"Barnham","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1179\/135100001101536436","article-title":"Role of nitric oxide in a progressive neurodegeneration model of Parkinson's disease in the rat","volume":"6","author":"Barthwal","year":"2001","journal-title":"Redox Rep."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib6","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1096\/fj.04-1945fje","article-title":"Nanometer size diesel exhaust particles are selectively toxic to dopaminergic neurons: the role of microglia, phagocytosis, and NADPH oxidase","volume":"18","author":"Block","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: uncovering the molecular mechanisms","volume":"8","author":"Block","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3940(95)12192-7","article-title":"Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients","volume":"202","author":"Blum-Degen","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib9","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.exphem.2010.06.012","article-title":"The cytokine\/chemokine pattern in the bone marrow environment of multiple myeloma patients","volume":"38","author":"Cao","year":"2010","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib10","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.1523\/JNEUROSCI.23-13-05877.2003","article-title":"Thrombin-induced microglial activation produces degeneration of nigral dopaminergic neurons in\u00a0vivo","volume":"23","author":"Choi","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib11","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1476-5381.2009.00022.x","article-title":"Inhibition of inducible NO synthase, cyclooxygenase-2 and interleukin-1beta by torilin is mediated by mitogen-activated protein kinases in microglial BV2 cells","volume":"156","author":"Choi","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib12","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1460-9568.2002.01938.x","article-title":"Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging","volume":"15","author":"Cicchetti","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/neur.1996.0020","article-title":"Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model","volume":"5","author":"Czlonkowska","year":"1996","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.neuropharm.2015.04.037_bib14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/1567202611666140318114037","article-title":"A\u00a0PPAR-beta\/delta agonist is neuroprotective and decreases cognitive impairment in a rodent model of Parkinson's disease","volume":"11","author":"Das","year":"2014","journal-title":"Curr. Neurovasc Res."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib15","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.nbd.2009.11.018","article-title":"Chronic expression of low levels of tumor necrosis factor-alpha in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia\/macrophage activation","volume":"37","author":"De Lella Ezcurra","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib16","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1046\/j.1471-4159.2000.0742213.x","article-title":"Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in\u00a0vivo","volume":"74","author":"Dehmer","year":"2000","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib17","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3109\/07420528.2012.762011","article-title":"Lack of long-term changes in circadian, locomotor, and cognitive functions in acute and chronic MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse models of Parkinson's disease","volume":"30","author":"Fifel","year":"2013","journal-title":"Chronobiol Int."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1017\/S0317167100009707","article-title":"Neuropsychiatric behaviors in the MPTP marmoset model of Parkinson's disease","volume":"37","author":"Fox","year":"2010","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib19","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1046\/j.1471-4159.2002.00928.x","article-title":"Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease","volume":"81","author":"Gao","year":"2002","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib20","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1523\/JNEUROSCI.23-15-06181.2003","article-title":"Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons","volume":"23","author":"Gao","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0378-8741(96)01492-4","article-title":"Hypolipidaemic activity of alpha-asarone in mice","volume":"55","author":"Garduno","year":"1997","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib22","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/BF01291788","article-title":"Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man","volume":"103","author":"Gerlach","year":"1996","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib23","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/jnen\/62.11.1144","article-title":"MPP+ induces the endoplasmic reticulum stress response in rabbit brain involving activation of the ATF-6 and NF-kappaB signaling pathways","volume":"62","author":"Ghribi","year":"2003","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev.neuro.22.1.219","article-title":"Microglia as mediators of inflammatory and degenerative diseases","author":"Gonz\u00e1lez-Scarano","year":"1999","journal-title":"Annu Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib25","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"issue":"18 Suppl.\u00a0l","key":"10.1016\/j.neuropharm.2015.04.037_bib26","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","article-title":"Neuroinflammation in Parkinson's disease","volume":"1","author":"Hirsch","year":"2012","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cyto.2007.07.185","article-title":"The proinflammatory cytokines TNF-alpha and IL-1 beta impair economy of contraction in human myocardium","volume":"39","author":"Hofmann","year":"2007","journal-title":"Cytokine"},{"key":"10.1016\/j.neuropharm.2015.04.037_bib28","doi-asserted-by":"crossref","first-page":"7531","DOI":"10.1073\/pnas.94.14.7531","article-title":"Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease","volume":"94","author":"Hunot","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2015.04.037_bib29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF03036449","article-title":"MPTP and SNpc DA neuronal vulnerability: role of dopamine, superoxide and nitric oxide in neurotoxicity","volume":"7","author":"Jackson-Lewis","year":"2005","journal-title":"Minireview. Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib30","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1254\/jphs.09239FP","article-title":"MMHD [(S,E)-2-methyl-1-(2-methylthiazol-4-yl) hexa-1,5-dien-ol], a novel synthetic compound derived from epothilone, suppresses nuclear factor-kappaB-mediated cytokine expression in lipopolysaccharide-stimulated BV-2 microglia","volume":"112","author":"Jeon","year":"2010","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib31","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jep.2012.09.026","article-title":"Acorus gramineus inhibits microglia mediated neuroinflammation and prevents neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson's disease","volume":"144","author":"Jiang","year":"2012","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neuro.2011.12.019","article-title":"Molecular effects of activated BV-2 microglia by mitochondrial toxin 1-methyl-4-phenylpyridinium","volume":"33","author":"Jin","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuropharm.2015.04.037_bib33","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1111\/j.1471-4159.2009.06112.x","article-title":"Activation of p38 MAPK in the substantia nigra leads to nuclear translocation of NF-kappaB in MPTP-treated mice: implication in Parkinson's disease","volume":"109","author":"Karunakaran","year":"2009","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib34","doi-asserted-by":"crossref","first-page":"e55792","DOI":"10.1371\/journal.pone.0055792","article-title":"Regulation of microglia activity by glaucocalyxin-A: attenuation of lipopolysaccharide-stimulated neuroinflammation through NF-kappaB and p38 MAPK signaling pathways","volume":"8","author":"Kim","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2015.04.037_bib35","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1254\/jphs.10324FP","article-title":"Anti-neuroinflammatory activity of Kamebakaurin from Isodon japonicus via inhibition of c-Jun NH-terminal kinase and p38 mitogen-activated protein kinase pathway in activated microglial cells","volume":"116","author":"Kim","year":"2011","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib36","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.nlm.2006.11.005","article-title":"The ameliorating effect of oroxylin A on scopolamine-induced memory impairment in mice","volume":"87","author":"Kim","year":"2007","journal-title":"Neurobiol. Learn Mem."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib37","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/j.neurobiolaging.2011.08.011","article-title":"Microglia-inhibiting activity of Parkinson's disease drug amantadine","volume":"33","author":"Kim","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2015.04.037_bib38","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/jnr.20562","article-title":"Microglia in health and disease","volume":"81","author":"Kim","year":"2005","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib39","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1523\/JNEUROSCI.20-16-06309.2000","article-title":"Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia","volume":"20","author":"Kim","year":"2000","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib40","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1006\/mcne.2000.0914","article-title":"Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2","volume":"16","author":"Knott","year":"2000","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib41","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/0024-3205(76)90408-2","article-title":"Tolerance to d-amphetamine: behavioral specificity","volume":"18","author":"Kokkinidis","year":"1976","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib42","doi-asserted-by":"crossref","first-page":"823902","DOI":"10.1155\/2012\/823902","article-title":"Reactive oxygen species and inhibitors of inflammatory enzymes, NADPH oxidase, and iNOS in experimental models of Parkinson's disease","volume":"2012","author":"Koppula","year":"2012","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib43","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1271\/bbb.120247","article-title":"Cognitive enhancing effects of alpha asarone in amnesic mice by influencing cholinergic and antioxidant defense mechanisms","volume":"76","author":"Kumar","year":"2012","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib44","doi-asserted-by":"crossref","first-page":"514095","DOI":"10.1155\/2013\/514095","article-title":"Gastrodin protects apoptotic dopaminergic neurons in a toxin-induced Parkinson's disease model","volume":"2013","author":"Kumar","year":"2013","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib45","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neulet.2013.03.032","article-title":"Poly(ADP-ribose) polymerase mediates both cell death and ATP decreases in SIRT2 inhibitor AGK2-treated microglial BV2 cells","volume":"544","author":"Li","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib46","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s12031-007-0058-8","article-title":"Function of COX-2 and prostaglandins in neurological disease","volume":"33","author":"Liang","year":"2007","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib47","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","article-title":"Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease","volume":"5","author":"Liberatore","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib48","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neulet.2009.02.011","article-title":"Neuroprotective effect of alpha-asarone on spatial memory and nitric oxide levels in rats injected with amyloid-beta((25-35))","volume":"453","author":"Limon","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib49","doi-asserted-by":"crossref","first-page":"692621","DOI":"10.1155\/2012\/692621","article-title":"Traditional chinese medicine for senile dementia","volume":"2012","author":"Lin","year":"2012","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib50","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2174\/1871527314666150225124348","article-title":"The effect of Acori graminei Rhizoma and extract fractions on spatial memory and Hippocampal Neurogenesis in amyloid beta 1-42 injected mice","volume":"14","author":"Ma","year":"2015","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.neuropharm.2015.04.037_bib51","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.phrs.2005.07.007","article-title":"Antioxidant property of alpha-asarone against noise-stress-induced changes in different regions of rat brain","volume":"52","author":"Manikandan","year":"2005","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib52","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbr.2012.08.017","article-title":"Neuroprotective effects of agmatine in mice infused with a single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"235","author":"Matheus","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-0270(96)02211-X","article-title":"Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion","volume":"73","author":"Matsuura","year":"1997","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2015.04.037_bib54","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.mehy.2006.01.013","article-title":"Down-regulation of microglial activation may represent a practical strategy for combating neurodegenerative disorders","volume":"67","author":"McCarty","year":"2006","journal-title":"Med. Hypotheses"},{"issue":"Suppl.\u00a0l","key":"10.1016\/j.neuropharm.2015.04.037_bib55","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.parkreldis.2004.01.005","article-title":"Inflammation and neurodegeneration in Parkinson's disease","volume":"10","author":"McGeer","year":"2004","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib56","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/ana.10728","article-title":"Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration","volume":"54","author":"McGeer","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib57","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","article-title":"Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients","volume":"165","author":"Mogi","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib58","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2174\/18715273113129990059","article-title":"Strategic selection of neuroinflammatory models in Parkinson's disease: evidence from experimental studies","volume":"12","author":"More","year":"2013","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.neuropharm.2015.04.037_bib59","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1471-4159.2011.07608.x","article-title":"Reduced calcium\/calmodulin-dependent protein kinase II activity in the hippocampus is associated with impaired cognitive function in MPTP-treated mice","volume":"120","author":"Moriguchi","year":"2012","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib60","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1600-0404.1998.tb01736.x","article-title":"Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson's disease","volume":"98","author":"Muller","year":"1998","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib61","first-page":"277","article-title":"Changes in cytokines and neurotrophins in Parkinson's disease","author":"Nagatsu","year":"2000","journal-title":"J.\u00a0Neural Transm. Suppl."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib62","first-page":"143","article-title":"Cytokines in Parkinson's disease","author":"Nagatsu","year":"2000","journal-title":"J.\u00a0Neural Transm. Suppl."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib63","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1124\/jpet.103.059519","article-title":"Dopaminergic agonists and muscarinic antagonists improve lateralization in hemiparkinsonian rats in a novel exploratory Y-maze","volume":"309","author":"Nakagawa","year":"2004","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib64","first-page":"141","article-title":"Functional roles of microglia in the central nervous system","volume":"11","author":"Nakajima","year":"1998","journal-title":"Hum. Cell."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib65","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0024-3205(01)00967-5","article-title":"NF-kappaB activation and IkappaB alpha dynamism involved in iNOS and chemokine induction in astroglial cells","volume":"68","author":"Nomura","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib66","first-page":"21","article-title":"Elevated plus maze and y-maze behavioral effects of subchronic, oral low dose monosodium glutamate in Swiss albino mice","volume":"3","author":"Onaolapo","year":"2012","journal-title":"J.\u00a0Pharm. Biol. S. C."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib67","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0301-0082(02)00127-2","article-title":"An inflammatory review of Parkinson's disease","volume":"68","author":"Orr","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib68","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neures.2010.08.011","article-title":"Activities of alpha-asarone in various animal seizure models and in biochemical assays might be essentially accounted for by antioxidant properties","volume":"68","author":"Pages","year":"2010","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib69","doi-asserted-by":"crossref","first-page":"e70274","DOI":"10.1371\/journal.pone.0070274","article-title":"Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson's disease","volume":"8","author":"Paumier","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2015.04.037_bib70","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12640-009-9087-0","article-title":"Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL\/6 mice models early preclinical phase of Parkinson's disease","volume":"17","author":"Prediger","year":"2010","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib71","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1073\/pnas.93.10.4565","article-title":"Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity","volume":"93","author":"Przedborski","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2015.04.037_bib72","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1046\/j.1471-4159.2002.01210.x","article-title":"Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species","volume":"83","author":"Qin","year":"2002","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib73","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1074\/jbc.M307657200","article-title":"NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia","volume":"279","author":"Qin","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib74","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0165-0173(99)00007-7","article-title":"Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function","volume":"30","author":"Raivich","year":"1999","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib75","doi-asserted-by":"crossref","first-page":"e114216","DOI":"10.1371\/journal.pone.0114216","article-title":"Behavioral phenotyping of Parkin-deficient mice: looking for early preclinical features of Parkinson's disease","volume":"9","author":"Rial","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2015.04.037_bib76","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF00212843","article-title":"Attenuation of scopolamine-induced impairment of spontaneous alteration behaviour by antagonist but not inverse agonist and agonist beta-carbolines","volume":"94","author":"Sarter","year":"1988","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib77","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4062\/biomolther.2013.102","article-title":"Alpha-asarone Ameliorates memory deficit in lipopolysaccharide-treated mice via suppression of pro-inflammatory cytokines and microglial activation","volume":"22","author":"Shin","year":"2014","journal-title":"Biomol. Ther. Seoul."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib78","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.neurobiolaging.2007.04.006","article-title":"Synuclein activates microglia in a model of Parkinson's disease","volume":"29","author":"Su","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2015.04.037_bib79","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1196\/annals.1366.012","article-title":"Roles of glia-derived cytokines on neuronal degeneration and regeneration","volume":"1088","author":"Suzumura","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib80","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00441-004-0944-0","article-title":"Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation","volume":"318","author":"Teismann","year":"2004","journal-title":"Cell. Tissue Res."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib81","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1749-6632.2003.tb07482.x","article-title":"COX-2 and neurodegeneration in Parkinson's disease","volume":"991","author":"Teismann","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib82","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.phrs.2013.02.002","article-title":"A\u00a0kavalactone derivative inhibits lipopolysaccharide-stimulated iNOS induction and NO production through activation of Nrf2 signaling in BV2 microglial cells","volume":"71","author":"Terazawa","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib83","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/exnr.2002.8021","article-title":"Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"178","author":"Tillerson","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib84","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11011-007-9080-3","article-title":"Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease","volume":"23","author":"Watanabe","year":"2008","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib85","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.bjp.0707167","article-title":"Inflammation as a causative factor in the aetiology of Parkinson's disease","volume":"150","author":"Whitton","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib86","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1096\/fj.02-0314fje","article-title":"Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease","volume":"17","author":"Wilms","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2015.04.037_bib87","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1089\/ars.2005.7.654","article-title":"The role of microglia in paraquat-induced dopaminergic neurotoxicity","volume":"7","author":"Wu","year":"2005","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.neuropharm.2015.04.037_bib88","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.biocel.2013.06.005","article-title":"Neuron-derived IgG protects dopaminergic neurons from insult by 6-OHDA and activates microglia through the FcgammaR I and TLR4 pathways","volume":"45","author":"Zhang","year":"2013","journal-title":"Int. J. Biochem. Cell. Biol."}],"updated-by":[{"DOI":"10.1016\/j.neuropharm.2017.02.023","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000}}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815001689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815001689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T13:53:57Z","timestamp":1706018037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390815001689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":88,"alternative-id":["S0028390815001689"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.04.037","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.neuropharm.2017.02.023","asserted-by":"object"}]},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b1-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.04.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}